Reproductive effects of prenatal exposure to nonylphenol on zebrafish (Danio rerio).
Mature female and male zebrafish were separated and exposed to nonylphenol (NP) at 0.1, 1, 10, 50, 100 and 500 microg/L, respectively, for 3 weeks. Gonadosomatic index (GSI) in both sexes and vitellogenin (VTG) induction in males was measured as the bioindicators for the impairment to the parents. The results indicated that 50 microg/L of NP was the non-observed effect concentration (NOEC) for GSI and VTG induction. Afterwards, the 50 microg/L NP exposed females and males, and the control females and males were cross-wise pair-bred in the control water for one week to examine the reproductive effects. The embryonic cathepsin D (CAT D) activity, eggshell thickness, fecundity, hatching rate and malformation (vertebral column flexure) rate of offspring were determined in the four pair-bred groups. While endpoints remained unchanged in the groups with exposed males, prenatal exposure of females to 50 microg/L of NP resulted in the impairment of reproduction in groups with exposed females including inhibition of CAT D activity (P < 0.05), decrease of eggshell thickness (by 23.6%) and elevation of malformation rate (P < 0.001). These results suggested NP could induce reproductive damage to zebrafish at NOEC for parents. The results also imply that alterations of CAT D activity and eggshell thickness may be more sensitive biomarkers to indicate the reproductive effects caused by endocrine disrupting chemicals.
Yang
Fang-Xing
FX
State Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China.
Xu
Ying
Y
Hui
Yang
Y
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002402:Cathepsin D / Q000378:metabolism; D004625:Embryo, Nonmammalian / Q000378:metabolism; D052244:Endocrine Disruptors / Q000494:pharmacology*; D005260:Female; D006066:Gonads / Q000033:anatomy & histology / Q000187:drug effects; D007814:Larva / Q000187:drug effects; D008297:Male; D009929:Organ Size / Q000187:drug effects; D010063:Ovum / Q000187:drug effects; D010636:Phenols / Q000494:pharmacology*; D012098:Reproduction / Q000187:drug effects*; D014819:Vitellogenins / Q000378:metabolism; D015027:Zebrafish / Q000502:physiology*
D052244:Endocrine Disruptors; D010636:Phenols; D014819:Vitellogenins; C025256:nonylphenol; D002402:Cathepsin D